Skip to content

Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma

Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma - Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020412
Enrollment
40
Registered
2015-12-31
Start date
2015-04-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

None listed

Sponsors

Nagoya City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Object: stable asthmatic patients Control: patients undergoing routine chest CT for small nodules or small gland glass opacities in peripheral lung (early lung cancer and atypical adenomatous hyperplasia) without airway disease such as asthma

Exclusion criteria

Exclusion criteria: If patients meet the following criteria, they are excluded. Patients who i. have respiratory tract infection or other respiratory disease within 4 weeks prior to enrollment ii. have asthma attacks within 4 weeks prior to enrollment iii. use anti-allergy drugs or inhaled anticholinergic drugs within 2 weeks prior to enrollment iv. use systemic corticosteroids within 4 weeks prior to enrollment v. currently smoke, had smoking history with 5 pack-years or more, or had quitted smoking within 6 months prior to the enrollment vi. prepare for pregnancy, in pregnancy or breast-feeding vii. unsuitable for the study

Design outcomes

Primary

MeasureTime frame
The correlation between the concentration of sputum supernatant and serum RELM-beta and the index of airway wall thickness on chest CT in bronchial asthma

Countries

Japan

Contacts

Public ContactHiroya Ichikawa

Nagoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology

cartgreengreengreen@gmail.com052-853-8216

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026